Evidence map›Paper›PMID 37396661›Full record

ArticleFrontiers in aging neuroscience2023

Percutaneous angioplasty and/or stenting versus aggressive medical therapy in patients with symptomatic intracranial atherosclerotic stenosis: a 1-year follow-up study.

Xiaohui Li, Xiaodan Qin, Chengfang Liu, Lin Zhu, Meng Wang, Teng Jiang, Yukai Liu, Shuo Li, Hongchao Shi, Huiling Sun and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in aging neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Effect of MR-guided perfusion imaging mismatch profiles within 6 h on endovascular thrombectomy outcomes.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xiaohui Li *Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Xiaodan Qin *General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Chengfang Liu *Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Lin ZhuDepartment of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Meng WangDepartment of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Teng JiangDepartment of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Yukai LiuDepartment of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Shuo LiDepartment of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Hongchao ShiDepartment of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Huiling SunGeneral Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Qiwen DengDepartment of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Junshan ZhouDepartment of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Symptomatic intracranial atherosclerotic stenosis (sICAS) is one of the common causes of ischemic stroke. However, the treatment of sICAS remains a challenge in the past with unfavorable findings. The purpose of this study was to explore the effect of stenting versus aggressive medical management on preventing recurrent stroke in patients with sICAS. Methods: We prospectively collected the clinical information of patients with sICAS who underwent percutaneous angioplasty and/or stenting (PTAS) or aggressive medical therapy from March 2020 to February 2022. Propensity score matching (PSM) was employed to ensure well-balanced characteristics of two groups. The primary outcome endpoint was defined as recurrent stroke or transient ischemic attack (TIA) within 1 year. Results: We enrolled 207 patients (51 in the PTAS and 156 in the aggressive medical groups) with sICAS. No significant difference was found between PTAS group and aggressive medical group for the risk of stroke or TIA in the same territory beyond 30 days through 6 months ( Conclusion: The PTAS has similar treatment outcomes compared with aggressive medical therapy in patients with sICAS across 1-year follow-up.

Indexed as

ischemic strokepercutaneous transluminal angioplasty and stentingpropensity score matchingrecurrent strokesymptomatic intracranial atherosclerotic stenosis

Identifiers

PMID37396661
PMCPMC10313453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.